<DOC>
	<DOCNO>NCT03090997</DOCNO>
	<brief_summary>Hormonal metabolic change postmenopause increase body weight , central abdominal fat , alter lipid profile insulin resistance , factor increase risk 60 % develop metabolic syndrome , diabetes cardiovascular disease . Because efficient antioxidant therapy postmenopausal woman , study proposes therapy resveratrol vitamin C increase total antioxidant capacity ; well decrease insulin resistance consequence decrease risk diabetes , metabolic syndrome cardiovascular disease</brief_summary>
	<brief_title>Effect Resveratrol Vitamin C Insulin Resistance Among Postmenopausal Women</brief_title>
	<detailed_description>Currently , study demonstrate efficient antioxidant therapy postmenopausal woman , increase total antioxidant capacity decrease insulin resistance biochemical parameter cardio-metabolic risk . Therefore , aim study evaluate effect co-administration resveratrol vitamin C insulin resistance antioxidant capacity double-blind randomize clinical trial . A population 270 postmenopausal woman study , stratify 3 group : Group 1 : Three-month administration vitamin C 500 mg daily + placebo Group 2 : Three-month administration resveratrol 500 mg daily + placebo Group 3 : Three month administration vitamin C 500 mg daily resveratrol 500 mg daily antioxidant therapy . All participant monitor monthly period 3 month : glucose , insulin , uric acid , Homeostatic Model Assessment ( HOMA ) , total cholesterol ( TC ) , triglyceride ( TGC ) , High density lipoproteins-cholesterol ( HDL- C ) , low density lipoproteins-cholesterol ( LDL ) , blood pressure , body mass index ( BMI ) . The antioxidant efficiency erythrocytes quantification antioxidant enzyme ( superoxide dismutase , catalase , glutathione reductase glutathione peroxidase ) , well total antioxidant capacity plasma . In order corroborate oxidative damage , product lipoperoxidation malondialdehyde carbonylation protein evaluate spectrophotometric technique three month intervention .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Women diagnose early postmenopause accord STRAW classification . Insulin resistance determinated HOMA â‰¥ 2.5 . Not use metformin , bezafibrates / statin , three month enter study No indication hormone replacement therapy . Sign inform consent . Women present pathology : Diabetes Mellitus , rheumatoid arthritis , lupus , neoplasms type , HIV , kidney disease course study . Women development protocol require hormone replacement therapy . Any type surgical intervention follow study . That patient wish withdraw study . That patient complete 80 % adherence treatment</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>resveratrol , vitamin C , antioxidant therapy , antioxidant capacity</keyword>
</DOC>